Skip to Navigation
London School of Hygiene & Tropical Medicine Malaria Centre

Drug development & resistance


Photograph courtesy of Teun Bousema

Even to stand still against malaria, we need constantly to develop new drugs; the parasite is highly effective at evolving resistance to drugs, which then spreads, leading to a dangerous fall in the effectiveness of treatment.

To advance we need new drug classes against new targets. Members of the Malaria Centre are involved in mapping the spread of drug resistance in Africa and Asia, understanding the reasons for it and the development of new drugs against P falciparum and P vivax malaria. Whilst most of this work is undertaken in support of malaria-endemic countries, members of the Malaria Centre also collaborate with colleagues in the NHS to understand drug resistance in travellers presenting with malaria in UK hospitals.


20 item(s)
Khalid Beshir
Research Assistant: Malaria Drug Resistance
Peter Chiodini
Honorary Professor
Taane Clark
Reader in Genetic Epidemiology and Statistics
Johnathan Cox
Senior Lecturer
Bianca DSouza
ACT Consortium Manager
Colin Sutherland

Colin Sutherland

Malaria Centre Head of Drug Development and Resistance

Head of Reader in Parasitology and Head of Department of Immunology and Infection and

020 7927 2338
020 7636 8739